Statistics for Retifanlimab Versus Placebo in Combination With Platinum-Based Chemotherapy in Patients With First-Line Non-Squamous or Squamous Metastatic Non-Small Lung Cancer (POD1UM-304): A Phase 3, Multiregional, Placebo-Controlled, Double-Blind, Randomised Study
Total visits
| views | |
|---|---|
| Retifanlimab Versus Placebo in Combination With Platinum-Based Chemotherapy in Patients With First-Line Non-Squamous or Squamous Metastatic Non-Small Lung Cancer (POD1UM-304): A Phase 3, Multiregional, Placebo-Controlled, Double-Blind, Randomised Study | 3 |
Total visits per month
| views | |
|---|---|
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 1 |
| January 2026 | 2 |
| February 2026 | 0 |
| March 2026 | 0 |
Top country views
| views | |
|---|---|
| China | 3 |